3 ms·

in patients with Type 2 diabetes

• beardedwizard 2y ago
  this part was both clear and unclear to me - does it exclude patients using it for weight loss or not?
  • mikaraento 2y ago
    They didn't study patients using semaglutide for weight loss only. I guess a Bayesian would increase their estimated probability of such a problem also for the weight loss case, but not by as much (as diabetes predisposes people to other ailments).
    • beardedwizard 2y ago
      What you are saying makes sense. Subjectively I feel like they could have done a better job at making this distinction clear given the explosive use for weight loss - but maybe it's just because my interest in this is outside of diabetes.